Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Cancer
Biotech
Sanofi, GSK ink preclinical pacts in hunt for new antibodies
Sanofi is investing in a U.S. biotech’s autoimmune research, while GSK has tapped Oxford BioTherapeutics to discover new cancer antibodies.
Darren Incorvaia
Dec 10, 2025 11:15am
Natera buys Foresight Diagnostics in $450M cancer testing deal
Dec 5, 2025 11:57am
Freenome to go public in $330M SPAC deal
Dec 5, 2025 10:35am
GE HealthCare, Mayo to tap digital twins for radiation therapy
Dec 4, 2025 12:06pm
Novocure replaces CEO after less than a year
Dec 2, 2025 9:35am
Abbott inks $23B deal for Exact Sciences in cancer testing buy
Nov 20, 2025 10:30am
